HUWE1 promotes EGFR ubiquitination and degradation to protect against renal tubulointerstitial fibrosis

Abstract

Injury of renal tubular epithelial cells is a key feature of the pathogenicity associated with tubulointerstitial fibrosis and other kidney diseases. HUWE1, an E3 ubiquitin ligase, acts by participating in ubiquitination and degradation of its target proteins. However, the detailed mechanisms by which HUWE1 might regulate fibrosis in renal tubular epithelial cells have not been established. Here, the possible regulation of renal tubulointerstitial fibrosis by HUWE1 was investigated by examining the expression of HUWE1 and EGFR in unilateral ureteral obstruction (UUO) mice. Markedly consistent reciprocal changes in HUWE1 and EGFR expression were observed at the protein and mRNA levels in the kidney after UUO injury. Expression of HUWE1 inhibited TGF‐β‐induced injury to HK‐2 cells, while HUWE1 overexpression decreased the expression of EGFR. Further analysis indicated that HUWE1 physically interacted with EGFR and promoted its ubiquitination and degradation. HUWE1 expression also showed clinical relevance in renal disease, as it notably decreased in multiple types of clinical nephropathy, while EGFR expression significantly increased when compared to the normal kidney. Therefore, this study demonstrated that HUWE1, which serves as an E3 ubiquitin ligase specific for EGFR, promotes EGFR ubiquitination and degradation, thereby regulating EGFR expression and providing protection against kidney injury.

ZC3H15 promotes glioblastoma progression through regulating EGFR stability

“…Interestingly, ZC3H15 positively regulated the protein ability of EGFR. Given that EGFR can be ubiquitinated by E3 ligases, meanwhile, we found that the ubiquitination level of EGFR was reduced in the existence of ZC3H15 [ 40 , 41 ]. It is noteworthy that, ZC3H15 has no Ring finger domain or HECT domain, which is crucial for targeting protein degradation [ 42 ].…”

Effect of Fushengong Decoction on PTEN/PI3K/AKT/NF-κB Pathway in Rats With Chronic Renal Failure via Dual-Dimension Network Pharmacology Strategy

“…Further analysis showed that AKT1, EGFR, and TNF may be potential targets for FSGD in the treatment of CRF, and the PPI network indicated that AKT1 was one of the central genes related to 40 highly valuable targets and is closely related to fibrosis, and it may be a new target for CRF ( Lin et al, 2020 ). AKT1 can promote EGFR ubiquitination and degradation to prevent renal intertubule fibrosis ( Zhu et al, 2020 ). Neutralizing inflammatory cytokines (TNF) can reduce the level of FGF23 in animal models of chronic kidney disease (CKD) and high levels of FGF23 are associated with increased cardiovascular morbidity and mortality in patients with CKD ( Egli-Spichtig et al, 2019 ).…”

Network Pharmacology and In Vivo Analysis of Dahuang-Huangqi Decoction Effectiveness in Alleviating Renal Interstitial Fibrosis

“…Obstructive nephropathy activates the EGFR signaling pathway, which regulates renal cell growth, survival, and proliferation. Overexpression of EGFR could increase the expression and activation of TGF- β 1 and the release of inflammatory cytokines like IL-6 [ 44 ]. IL-6 is a pleiotropic cytokine with a wide range of functions.…”